<DOC>
	<DOC>NCT02433366</DOC>
	<brief_summary>The key focus of this survey will be to collect data on physicians awareness of the content of the Pradaxa速 Prescriber Guide and the extent to which risk awareness is communicated to patients. The data collected with atrial fibrillation patients will show if and how well this information is received and understood.</brief_summary>
	<brief_title>Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation</brief_title>
	<detailed_description>Purpose:</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion criteria: Pradaxa速 prescribers (cardiologists and primary care physicians) Patients with atrial fibrillation treated with Pradaxa速 Exclusion criteria: As defined in Summary of Product Characteristics for patients treated with Pradaxa速</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>